Bibliography
- Feng SS : Nanoparticles of biodegradable polymers for new concepts chemotherapy.Expert Rev. Med. Devices1, 115–125 (2004).
- Muthu MS , RajeshCV, MishraA, SinghS: Stimulus responsive targeted nanomicelles for effective cancer therapy.Nanomedicine (Lond.)4, 657–667 (2009).
- Huang C : Studies on phosphatidylcholine vesicles, formation and physical characteristics.Biochemistry8, 344–352 (1969).
- Lasic DD , PapahadjopoulosD: Medical Application of Liposomes. Elsevier, Amsterdam, The Netherlands (1998).
- Helfrich W : The size of bilayer vesicles generated by sonication.Phys. Lett. A50, 115–116 (1974).
- Bawarski WE , ChidlowskyE, BharaliDJ, MousaSA: Emerging nanopharmaceuticals.Nanomedicine4, 273–282 (2008).
- Feng SS , RuanG, LiQT: Fabrication and characterizations of a novel drug delivery device liposomes-in-microsphere (LIM).Biomaterials25, 5181–5189 (2004).
- Muthu MS , SinghS: Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders.Nanomedicine (Lond.)4, 105–118 (2009).
- Ogawara K , UnK, TanakaKet al.: In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: involvement of cytotoxic effect on vascular endothelial cells.J. Control. Release133, 4–10 (2009).
- Yokoyama M : Drug targeting with nano-sized carrier systems.J. Artif. Organs8, 77–84 (2005).
- Boulikas T : Clinical overview on Lipoplatin: a successful liposomal formulation of cisplatin.Expert Opin. Investig. Drugs18, 1197–1218 (2009).
- Batist G , BartonJ, Chaikin P et al.: Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy. Expert Opin. Pharmcother.3, 1739–1751 (2002).
- Zhang Q , HuangXE, GaoLL: A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors.Biomed. Pharmacother.63, 603–607 (2009).
- Yang A , LiJ, XuH, ChenH: A study on antitumor effect of liposome encapsulated paclitaxel in vivo and in vitro.Bull. Chin. Cancer15, 862–864 (2006).
- Chen Q , ZhangQ, LiuJet al.: Multi-center prospective randomized trial on paclitaxel liposome and traditional taxol in the treatment of breast cancer and non-small-cell lung cancer.Chin. J. Oncol.25, 190–192 (2003).
Websites
- Data Standards Manual (monographs): Dosage Form Link
- Liposome drug products www.fda.gov/ohrms/dockets/ac/01/slides/3763s2_08_martin/sld001.htm